BackIndo US Bio-Tech Limited Overview

Indo US Bio-Tech Limited Total Current Liabilities

Indo US Bio-Tech Limited's total current liabilities is $400M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$398.87M
↑ 37.12% YoYΔ $107.98M vs prior year quarter

Peer trimmed avg / median

Loading

Indo US Bio-Tech Limited Total Current Liabilities History

Loading

Indo US Bio-Tech Limited vs. peers: Total Current Liabilities Comparison

Loading

Indo US Bio-Tech Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Indo US Bio-Tech Limited (INDOUS.BO) FAQ

The latest total current liabilities for INDOUS.BO is $400M as of September 2026. That compares with $290M in the prior-year period — up 37.1% year over year. Investors often review this figure alongside Indo US Bio-Tech Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, INDOUS.BO's total current liabilities moved from $290M to $400M — a 37.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Indo US Bio-Tech Limited's operating scale or balance-sheet position.

A total current liabilities figure of $400M for INDOUS.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INDOUS.BO's total current liabilities ($400M), review year-over-year change from $290M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers